Find latest Myeloma videos · 500+ videos

This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub
M

ASH 2024 Insights: Genomic Determinants of Outcomes in MM With t(11;14) Treated With Venetoclax

By 2024 ASH Annual Meeting Insights Hub FEATURING Marcella Karddoura
By 2024 ASH Annual Meeting Insights Hub FEATURING Marcella Karddoura
14 views
December 19, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

2024 ASH Annual Meeting Insights Hub: Myeloma Videos

04:04

New

ASH 2024 Insights: Association of Pre-Treatment Biomarkers With Toxi…

2024 ASH Annual Meeting Insights Hub

D. Hansen

09:18

New

ASH 2024 Insights: Belamaf Monotherapy in Pts With R/R Light Chain A…

2024 ASH Annual Meeting Insights Hub

E. Kastritis

16 views
15:43

New

ASH 2024 Insights: Ph3 ANDROMEDA - Subcutaneous Dara + VCd in Newly …

2024 ASH Annual Meeting Insights Hub

E. Kastritis

17 views
View All

Related Videos

Penn Medicine Abramson Cancer Center

2025 Breast Cancer Highlights from International Medical Meetings: 5…

Thu, Mar 6, 2025
Total Health

2025 West Oncology Conference

Sat, Feb 8, 2025
21:06

New

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

394 views
15:00

FDA Approval of Isatuximab in 1L MM: Perspectives for Practice

Dana-Farber Cancer Institute

P. Richardson

710 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.0K views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

607 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
09:15

New

ASH 2024 Summary: Transplant in Myeloma - Key Factors in Decision-Ma…

2024 ASH Annual Meeting Insights Hub

A. Perrot

134 views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

688 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

633 views
21:41

Multiple Myeloma: Hot Topics in 2024

Yale Cancer Center

S. Browning

202 views
20:23

When to Consider Bispecific and CAR-T Therapy in MM

SOHO Brazil 2024

N. S. Raje

425 views
13:32

ASH 2024 Insights: Analyses of MRD Negativity Dynamics in the Phase …

2024 ASH Annual Meeting Insights Hub

R. Orlowski

106 views
04:55

New

ASH 2024 Insights: Dara vs. Len Maintenance in NDMM - Interim Result…

2024 ASH Annual Meeting Insights Hub

U. Shah

82 views
22:33

Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy

Integrity CE

S. Usmani, J. Hillengass

235 views
10:57

Indefinite Treatment of Multiple Myeloma: Strategies for Frail Patie…

Shaji Kumar

105 views
19:38

Fast Five Key Updates in Malignant Heme: Pearls From a Pharmacist

Total Health

S. Medeiros

166 views
24:23

Will CAR-Ts and Bispecifics Replace HSCT in Myeloma?

MyCancerHaven

R. Vij, S. Al Hadidi

631 views
28:20

Managing Newly Diagnosed MM in 2024

Indy Hematology Review

S. Usmani

705 views
36:10

Highlights in Plasma Cell Disorders From ASCO® and EHA

Insights from 2024 EHA Annual Meeting

S. Al Hadidi

481 views
13:15

ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?"

2024 ASCO® Annual Meeting Insights Hub

O. Landgren

420 views
19:20

Highlights of Recent Updates in Myeloma: Part 1 - Frontline Treatment

2024 ASCO® Annual Meeting Insights Hub

A. Jakubowiak

314 views
AUTOPLAY